Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Mikhailidis, DP; Elisaf, M; Rizzo, M; Berneis, K; Griffin, B; Zambon, A; Athyros, V; de Graaf, J; März, W; Parhofer, KG; Rini, GB; Spinas, GA; Tomkin, GH; Tselepis, AD; Wierzbicki, AS; Winkler, K; Florentin, M; Liberopoulos, E.
"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.
Curr Vasc Pharmacol. 2011; 9(5):533-571 Doi: 10.2174/157016111796642661
Web of Science PubMed FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
März Winfried
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Aim of the present Consensus Statement is to provide a comprehensive and up to-date document on the pathophysiology, atherogenicity and clinical significance of low density liproproteins (LDL) subclasses. We sub-divided our statement in 2 sections. section I discusses the pathophysiology, atherogenicity and measurement issues, while section II is focused on the effects of drug and lifestyle modifications. Suggestions for future research in the field are highlighted at the end of section II. Each section includes Conclusions.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Atherosclerosis - blood
Atherosclerosis - drug therapy
Atherosclerosis - epidemiology
Atherosclerosis - etiology
Atherosclerosis - genetics
Genetic Predisposition to Disease -
Humans -
Lipoproteins, LDL - blood
Lipoproteins, LDL - classification
Lipoproteins, LDL - genetics
Risk Factors -

Find related publications in this database (Keywords)
LDL
subclasses
atherosclerosis
cardiovascular risk
statement
© Med Uni Graz Impressum